$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000162828019006447 Filed on May 09, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$2.175M	$1.853M	$1.768M
YoY Change	-35.84%	4.78%	2.77%
Cost Of Revenue	$1.555M	$1.147M	$841.4K
YoY Change	-14.25%	36.31%	-30.19%
Gross Profit	$620.0K	$706.0K	$927.0K
YoY Change	-60.67%	-23.84%	79.84%
Gross Profit Margin	28.51%	38.1%	52.42%
Selling, General & Admin	$5.056M	$4.791M	$2.895M
YoY Change	44.87%	65.47%	-17.51%
% of Gross Profit	815.48%	678.61%	312.33%
Research & Development	$2.408M	$2.100M	$2.367M
YoY Change	14.73%	-11.28%	-25.8%
% of Gross Profit	388.39%	297.45%	255.34%
Depreciation & Amortization	$267.0K	$270.0K	$391.5K
YoY Change	-31.04%	-31.03%	11.84%
% of Gross Profit	43.06%	38.24%	42.23%
Operating Expenses	$7.464M	$6.891M	$5.262M
YoY Change	33.55%	30.95%	-21.46%
Operating Profit	-$6.844M	-$6.185M	-$4.335M
YoY Change	70.58%	42.66%	-29.9%
Interest Expense	$645.0K	$273.0K	$302.0K
YoY Change	58.23%	-9.6%	-315.7%
% of Operating Profit
Other Income/Expense, Net	-$816.0K	-$1.662M	$491.9K
YoY Change	-215.54%	-437.89%	-25.47%
Pretax Income	-$7.660M	-$7.847M	-$3.844M
YoY Change	131.7%	104.16%	-32.21%
Income Tax	$5.000K	$5.000K	$3.776K
% Of Pretax Income
Net Earnings	-$7.665M	-$7.852M	-$3.847M
YoY Change	131.47%	104.09%	-167.67%
Net Earnings / Revenue	-352.41%	-423.75%	-217.55%
Basic Earnings Per Share
Diluted Earnings Per Share	-$705.3K	-$768.9K	-$405.7K
COMMON SHARES
Basic Shares Outstanding	10.85M shares	10.10M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.30M	$20.80M	$7.600M
YoY Change	101.32%	173.68%
Cash & Equivalents	$15.29M	$20.83M	$7.553M
Short-Term Investments
Other Short-Term Assets	$465.5K	$1.374M	$1.700M
YoY Change	-85.45%	-19.18%
Inventory	$3.022M	$1.406M	$2.000M
Prepaid Expenses
Receivables	$4.984M	$4.057M	$2.500M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$23.93M	$28.01M	$13.80M
YoY Change	52.43%	103.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.279M	$1.537M	$2.600M
YoY Change	-46.71%	-40.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.279M	$1.537M	$2.700M
YoY Change	-46.71%	-43.07%
TOTAL ASSETS
Total Short-Term Assets	$23.93M	$28.01M	$13.80M
Total Long-Term Assets	$1.279M	$1.537M	$2.700M
Total Assets	$25.21M	$29.55M	$16.50M
YoY Change	39.29%	79.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.618M	$870.8K	$900.0K
YoY Change	100.99%	-3.24%
Accrued Expenses	$2.702M	$3.629M	$2.800M
YoY Change	-39.96%	29.6%
Deferred Revenue	$421.3K
YoY Change
Short-Term Debt	$800.0K	$0.00	$13.30M
YoY Change	-94.41%	-100.0%
Long-Term Debt Due			$6.700M
YoY Change
Total Short-Term Liabilities	$7.541M	$4.714M	$26.90M
YoY Change	-66.33%	-82.48%
LONG-TERM LIABILITIES
Long-Term Debt	$18.62M	$18.38M	$0.00
YoY Change	106.91%
Other Long-Term Liabilities	$173.8K	$287.3K	$600.0K
YoY Change	-82.62%	-52.11%
Total Long-Term Liabilities	$18.80M	$18.66M	$600.0K
YoY Change	87.95%	3010.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.541M	$4.714M	$26.90M
Total Long-Term Liabilities	$18.80M	$18.66M	$600.0K
Total Liabilities	$26.56M	$23.68M	$27.50M
YoY Change	-18.04%	-13.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$88.28M	-$80.61M
YoY Change
Common Stock	$86.93M	$86.48M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.345M	$5.870M	-$54.02M
YoY Change
Total Liabilities & Shareholders Equity	$25.21M	$29.55M	$16.50M
YoY Change	39.29%	79.1%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$7.665M	-$7.852M	-$3.847M
YoY Change	131.47%	104.09%	-167.67%
Depreciation, Depletion And Amortization	$267.0K	$270.0K	$391.5K
YoY Change	-31.04%	-31.03%	11.84%
Cash From Operating Activities	-$6.320M	-$6.552M	-$6.787M
YoY Change	113.51%	-3.47%	-7.9%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	$0.00	$11.83K
YoY Change	-83.33%	-100.0%	-116.9%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$30.00K	$0.00	-$11.83K
YoY Change	-83.33%	-100.0%	-83.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.410M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	810.0K	$10.86M	$13.33M
YoY Change	-74.84%	-18.54%	90.98%
NET CHANGE
Cash From Operating Activities	-6.320M	-$6.552M	-$6.787M
Cash From Investing Activities	-30.00K	$0.00	-$11.83K
Cash From Financing Activities	810.0K	$10.86M	$13.33M
Net Change In Cash	-5.540M	$4.307M	$6.531M
YoY Change	-7025.0%	-34.05%	-1519.74%
FREE CASH FLOW
Cash From Operating Activities	-$6.320M	-$6.552M	-$6.787M
Capital Expenditures	-$30.00K	$0.00	$11.83K
Free Cash Flow	-$6.290M	-$6.552M	-$6.799M
YoY Change	126.26%	-3.64%	-6.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	201789	USD
CY2018Q1	bngo	Loan Amendment Fee Due LoanAmendmentFeeDue	70000	USD
CY2019Q1	bngo	Loan Amendment Fee Due LoanAmendmentFeeDue	0	USD
CY2018Q1	bngo	Long Term Debt Prepayment Fees LongTermDebtPrepaymentFees	0	USD
CY2019Q1	bngo	Long Term Debt Prepayment Fees LongTermDebtPrepaymentFees	412000	USD
CY2019Q1	bngo	Operating Leases Future Minimum Payments Due Net OperatingLeasesFutureMinimumPaymentsDueNet	738433	USD
CY2019Q1	bngo	Operating Leases Future Minimum Payments Due Next Twelve Months Net OperatingLeasesFutureMinimumPaymentsDueNextTwelveMonthsNet	300355	USD
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001411690
CY2019Q1	bngo	Accretion Of Debt Discount AccretionOfDebtDiscount	-49130	USD
CY2018Q4	bngo	Accrued Expenses Current AccruedExpensesCurrent	2134981	USD
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10845020	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019Q1	bngo	Accrued Expenses Current AccruedExpensesCurrent	3432301	USD
CY2018Q4	bngo	Annual Future Minimum Royalty Payments AnnualFutureMinimumRoyaltyPayments	90000	USD
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	bngo	Fair Value Of Warrants Issued With Debt Classified As Liability FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability	0	USD
CY2019Q1	bngo	Fair Value Of Warrants Issued With Debt Classified As Liability FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability	629830	USD
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2018Q1	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	0	USD
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2018Q1	bngo	Accretion Of Debt Discount AccretionOfDebtDiscount	-21330	USD
CY2019Q1	bngo	Operating Leases Future Minimum Payments Duein Two Years Net OperatingLeasesFutureMinimumPaymentsDueinTwoYearsNet	438078	USD
CY2018	bngo	Purchase Obligation Contract Termination Period PurchaseObligationContractTerminationPeriod	P90D
CY2018	bngo	Purchase Obligation Initial Purchase Period PurchaseObligationInitialPurchasePeriod	P2Y
CY2018Q1	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	0	USD
CY2019Q1	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	29650	USD
CY2019Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	Bionano Genomics, Inc.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q1	dei	Trading Symbol TradingSymbol	BNGO
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1351736	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	870836	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4514333	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4057128	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	765148	USD
CY2019Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	196475	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	86483279	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	201789	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54444	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	289395	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	629830	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2900129	USD
CY2018Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54444	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	289395	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3628776	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5162364	USD
CY2018Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	21330	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5432203	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82898775	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	841449	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1147042	USD
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	5262497	USD
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	49130	USD
CY2019Q1	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	56263	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	177245659	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5931920	shares
CY2018Q4	us-gaap	Assets Assets	24802421	USD
CY2019Q1	us-gaap	Assets Assets	29551277	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	23025119	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	28014164	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16522729	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20830399	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1021897	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7552716	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16522729	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20830399	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6530819	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4307670	USD
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6426602	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10055072	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10845020	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10055072	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10845020	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1004	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	1083	USD
CY2019Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	6890713	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	270998	USD
CY2019Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	213898	USD
CY2018Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	304467	USD
CY2019Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	304467	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	391451	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	269839	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.16
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0006
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3700000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2018Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-953198	USD
CY2019Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-921496	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3843586	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7847257	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3776	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4486	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1355572	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-510550	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-816319	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-457205	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-920793	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	550506	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	320359	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	337275	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	673759	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	801305	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	301981	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	272504	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	907089	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1167705	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1068557	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	1405832	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	161468	USD
CY2019Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	238127	USD
CY2018Q4	us-gaap	Liabilities Liabilities	14665070	USD
CY2019Q1	us-gaap	Liabilities Liabilities	23681086	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24802421	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29551277	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4522863	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4713510	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9029374	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18375784	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13330148	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10858972	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11830	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6787499	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6551302	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-3847362	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-7851743	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	491875	USD
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1662248	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4335461	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6185009	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1536021	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	902412	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	797588	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	333254	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	464334	USD
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	633609	USD
CY2019Q1	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	105529	USD
CY2018Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	147522	USD
CY2019Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	46220	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	384131	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1373945	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	808366	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	287325	USD
CY2018Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	159342	USD
CY2019Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	468248	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11830	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	919500	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1720805	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	460684	USD
CY2019Q1	us-gaap	Prepaid Insurance PrepaidInsurance	321274	USD
CY2018Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	13329843	USD
CY2019Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2019Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	19207403	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	2409593	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	305	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	53976	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-3847362	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-7851743	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6939666	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6969316	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1777302	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1537113	USD
CY2018Q4	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	165000	USD
CY2018Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2019Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10812000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2367093	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2100111	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72762428	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80614171	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1768485	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1852746	USD
CY2018Q1	us-gaap	Royalty Expense RoyaltyExpense	86517	USD
CY2019Q1	us-gaap	Royalty Expense RoyaltyExpense	60558	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2895404	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4790602	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54444	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	289395	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.63
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.025
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.025
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y10M24D
CY2019Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	22179	shares
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	305	USD
CY2019Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2409593	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	53976	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-50227211	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-54019824	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10137351	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	5870191	USD
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0467
CY2018Q4	us-gaap	Supplies Supplies	74685	USD
CY2019Q1	us-gaap	Supplies Supplies	25586	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3315754	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10210755	shares

Files In Submission

Name	View Source	Status
0001628280-19-006447-index-headers.html	Edgar Link	pending
0001628280-19-006447-index.html	Edgar Link	pending
0001628280-19-006447.txt	Edgar Link	pending
0001628280-19-006447-xbrl.zip	Edgar Link	pending
bngo-20190331.xml	Edgar Link	completed
bngo-20190331.xsd	Edgar Link	pending
bngo-20190331x10q.htm	Edgar Link	pending
bngo-20190331xexx311.htm	Edgar Link	pending
bngo-20190331xexx312.htm	Edgar Link	pending
bngo-20190331xexx321.htm	Edgar Link	pending
bngo-20190331_cal.xml	Edgar Link	unprocessable
bngo-20190331_def.xml	Edgar Link	unprocessable
bngo-20190331_lab.xml	Edgar Link	unprocessable
bngo-20190331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2019 Q2 Form 10-Q Financial Statement

#000162828019006447 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2019 Q2 Form 10-Q Financial Statement

#000162828019006447 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo